Skip to main content
SpringerLink
Log in

Aldesleukin/gefitinib/regorafenib

Various toxicities: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Jiao Z, et al. Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database. Frontiers in Pharmacology 12: 25 Jan 2022. Available from: URL: http://doi.org/10.3389/fphar.2021.760013

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aldesleukin/gefitinib/regorafenib. Reactions Weekly 1908, 26 (2022). https://doi.org/10.1007/s40278-022-15754-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15754-5

Search

Navigation